Navigation Links
Infinata’s BioPharm Insight Releases Licensing League Tables Report for 4Q12 and YE12
Date:3/4/2013

Norwood, MA (PRWEB) March 04, 2013

Infinata’s BioPharm Insight released its Licensing League Tables Report for 4Q12 and YE12 to subscribers in mid-February. This report provides insight needed to evaluate market opportunities, market values and trends as well as competitive strategies.

The total volume and disclosed value of licensing agreements involving pharmaceutical products picked up in 4Q12. The quarter has seen 110 agreements with an aggregate disclosed value of USD 6,813m. That is an increase of 36% in volume and 42% in value from 3Q12, in which 81 agreements worth USD 4,787m were announced. The Antibody Program agreement between Menarini Group and Oxford BioTherapeutics was the largest deal in 4Q12, potentially valued at USD 1,035m.

Topping the charts in 4Q, legal advisor Wilson, Sonsini Goodrich & Rositi led the volume table having advised on eight transactions valued at USD 551m. While WilmerHale led the global value table for 4Q, having advised on six drug licensing agreements valued at USD 685m.

WilmerHale also led the global and North American volume tables for YE12 with 27 transactions valued at USD 1,283m, while tying with Cooley for the European volume tables, both having advised on eight transactions. Cooley also led the global and North American value tables for YE12 with 26 transactions valued at USD 4,280m and 25 transactions valued at USD 4,272m, respectively. Covington & Burling took the top spot for the European value table for YE12 having advised on seven agreements valued at USD 3,765m.

Access all of BioPharm Insight’s reports by starting a free trial today.

About BioPharm Insight
BioPharm Insight is the definitive guide to the global biopharma community
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Infinata’s BioPharm Insight Signs 200th Media Partner, Inaugurates Advertising Program
2. Infinata’s BioPharm Insight™ Achieves Record Growth in 2012
3. Infinata's BioPharm Insight Journalist Awarded Fellowship by Association of Health Care Journalists
4. PDL BioPharma to Present at Two Upcoming Investor Conferences
5. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
6. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
7. Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013
8. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
9. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
10. Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013
11. BioPharm Systems to Host Webinar on an Add-On Solution for Oracle Clinical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... More than 5 million Americans are ... 3 seniors will die with Alzheimer’s or another dementia, ... have shocked many Americans into looking for ways to ... tragic age-related cognitive disorders. Jonathan Weisman, president of Biohack ...
(Date:1/15/2014)... CA (PRWEB) January 15, 2014 ... research solutions, today announced that Lupin Limited, one of ... Freeslate’s CM Protégé PharmD System for high ... Mumbai, India, is focused on a wide range of ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Histogen, Inc., ... products of cells grown under simulated embryonic conditions, today ... agreement with Suneva Medical, Inc. for physician-dispensed aesthetic products ... , This agreement is an amendment to the ...
(Date:1/14/2014)... and BETHESDA, Md. , Jan. 14, ... with two institutes from the National Institutes of Health ... bringing safer, more effective treatments to patients on a ... for Advancing Translational Sciences (NCATS) and the National Eye ...
Breaking Biology Technology:Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
... TORONTO, Sept. 6, 2011 Generex Biotechnology Corporation ( ... of the Company,s reorganization plan and following a comprehensive ... assessment, the Company has completed the sales of two ... proceeds of just over $1,000,000.  The tenanted properties were ...
... 2011 The Immune Deficiency Foundation (IDF) announced today ... (CE) course for  nurses. The goal of this CE ... providing an educational update on primary immunodeficiency disease and ... national patient organization dedicated to improving the diagnosis, treatment ...
... OXIS International, Inc. (OTC Bulletin Board: OXIS ... Saloff as Chief Executive Officer.  Mr. Saloff was appointed to ... "David,s proven ability to move companies from development stage ... OXIS at this time," said Anthony J. Cataldo, Chairman of ...
Cached Biology Technology:Generex Augments Cash Position With Sales of Non-Essential Assets 2Generex Augments Cash Position With Sales of Non-Essential Assets 3Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy 2Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy 3OXIS International Names David Saloff as Chief Executive Officer 2OXIS International Names David Saloff as Chief Executive Officer 3
(Date:4/17/2014)... consumption advisories for expecting mothers are ineffective in ... organic pollutants (POPs). , The study, performed ... Toronto Scarborough PhD student Matt Binnington and Professor ... environmental contamination, a mother,s compliance with advisories, and ... exposure in her children. , Their model estimates ...
(Date:4/17/2014)... German . ... also provide us with a continuous stream of information about ... sit still in a car the world glides by ... Seemingly without effort, our brain calculates self-motion from this "optic ... a steady gaze during our own movements. Together with biologists ...
(Date:4/17/2014)... House honored Clemson professor Rajendra Singh Thursday as ... promote and expand solar deployment in the residential, ... Houser Banks Professor of Electrical and Computer Engineering ... is considered a local hero leading the charge ... opportunity in solar power and driving policy changes ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4White House honors Clemson professor as 'Champion of Change' for solar deployment 2
... news media splash photos of the company,s CEO around the ... Research the shape of the CEO,s face evokes judgments about ... what face is put on the crisis, and [our] research ... a trivial consideration," say authors Gerald J. Gorn, Yuwei Jiang ...
... Medical Research, led by Jos Luis Milln, Ph.D., have ... replacement therapy to prevent hypophosphatasia (HPP), a primary skeletal ... foundation for future clinical trials for HPP patients. ... that most commonly results from a lack of vitamin ...
... direct communication links between the human brain and ... themselves to changing environmental conditions, or computer chips ... medical technologies that eliminate currently untreatable conditions such ... these developments occurring at the same time. Far-fetched? ...
Cached Biology News:Potential therapy discovered for hypophosphatasia, a congenital form of rickets 2The coming convergence 2The coming convergence 3
... mutS are mismatch repair minus strains of ... repair of the newly synthesized unmethylated strand ... making them helpful in such systems as ... Systems. Both ES1301 and BMH 71-18 mutS ...
1 unit is sufficient for 1 caspase activity assay....
RABBIT ANTI WARFARIN...
Request Info...
Biology Products: